Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David N. Louis, M.D.

Co-Author

This page shows the publications co-authored by David Louis and E. Chiocca.
Connection Strength

0.520
  1. Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proc Natl Acad Sci U S A. 2006 Aug 22; 103(34):12873-8.
    View in: PubMed
    Score: 0.088
  2. A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. Mol Ther. 2004 Nov; 10(5):958-66.
    View in: PubMed
    Score: 0.078
  3. Massive growth of a meningioma into the brachial plexus and thoracic cavity after intraspinal and supraclavicular resection. Case report and review of the literature. J Neurosurg. 2002 Jan; 96(1 Suppl):107-11.
    View in: PubMed
    Score: 0.064
  4. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis. Cell. 2021 03 04; 184(5):1281-1298.e26.
    View in: PubMed
    Score: 0.060
  5. Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant. J Virol. 2000 May; 74(10):4765-75.
    View in: PubMed
    Score: 0.057
  6. Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses. Nat Med. 1999 Aug; 5(8):881-7.
    View in: PubMed
    Score: 0.054
  7. Development of a novel non-human primate model for preclinical gene vector safety studies. Determining the effects of intracerebral HSV-1 inoculation in the common marmoset: a comparative study. Gene Ther. 2003 Aug; 10(15):1225-33.
    View in: PubMed
    Score: 0.018
  8. Potentiated gene delivery to tumors using herpes simplex virus/Epstein-Barr virus/RV tribrid amplicon vectors. Hum Gene Ther. 2003 May 01; 14(7):611-26.
    View in: PubMed
    Score: 0.017
  9. In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. Radiology. 2002 Dec; 225(3):871-9.
    View in: PubMed
    Score: 0.017
  10. Primary lymphoma of peripheral nerve: report of four cases. Am J Surg Pathol. 2000 Sep; 24(9):1257-65.
    View in: PubMed
    Score: 0.015
  11. Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study. J Neurosurg. 2000 May; 92(5):804-11.
    View in: PubMed
    Score: 0.014
  12. Multicolumn infusion of gene therapy cells into human brain tumors: technical report. Neurosurgery. 2000 Mar; 46(3):663-8; discussion 668-9.
    View in: PubMed
    Score: 0.014
  13. Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector. Gene Ther. 1998 Jun; 5(6):809-19.
    View in: PubMed
    Score: 0.012
  14. Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines. Acta Neuropathol. 1998 Mar; 95(3):287-90.
    View in: PubMed
    Score: 0.012
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.